Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natural killer cell surface receptors are a heterogeneous group of membrane proteins expressed by NK cells that control their activation and cytotoxic functions through recognition of target cell ligands. These receptors are divided into activating and inhibitory types, and their signals are integrated via intracellular adapter proteins possessing ITAM or ITIM motifs[2][3][5][6][7][8]. Activating receptors (e.g., NKp30, NKp44, NKp46, NKG2D, CD16, DNAM-1) trigger NK cell-mediated killing, cytokine secretion, and regulation of immune responses; inhibitory receptors (e.g., KIRs, NKG2A, CD94) ensure self-tolerance by dampening inappropriate activation[5][7]. Dysregulation or therapeutic modulation of these pathways is implicated in cancer, infection, inflammation, and other diseases, making NK cell receptors important therapeutic targets in immunotherapy and beyond[7][8].
Blocking inhibitory receptors to promote NK cell activation (e.g., anti-KIR, anti-NKG2A antibody therapy) Stimulating activating receptors to increase cytotoxicity Modulating adapter protein signaling (ITAM, ITIM motifs[3][4][5][6])
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural killer cell surface receptor (NK cell receptor).